AVIXIS 0.025% SOLUCION TOPICA Peru - spansk - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

avixis 0.025% solucion topica

quimica suiza s.a.c. - alfatradiol; - solucion topica - por mililitro 5.00 ml - otros productos dermatológicos

AVIXIS solución capilar Uruguay - spansk - Ministerio de Salud (Dirección Oficina Central)

avixis solución capilar

gramon bago - solución capilar - alfatradiol 0,25 mg/ml solución capilar

Plavix Den europeiske union - finsk - EMA (European Medicines Agency)

plavix

sanofi winthrop industrie - klopidogreelin vetysulfaatti - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - antitromboottiset aineet - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event. ehkäisy aterotromboottisten ja tromboembolisten tapahtumien eteisen fibrillationin aikuisten eteisvärinäpotilailla, joilla on vähintään yksi verisuonitapahtumiin kuten tapahtumia, eivät sovellu hoito vitamiini-k-antagonistit ja joilla on vähäinen verenvuodon riski, klopidogreeli on tarkoitettu yhdistelmänä asa: n ehkäisyyn aterotromboottisten ja tromboembolisten tapahtumien, kuten aivoinfarktin.

OFLOXAVIS 3 mg/ml COLIRIO EN SOLUCIÓN Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

ofloxavis 3 mg/ml colirio en solución

pharma stulln gmbh - ofloxacino - colirio en soluciÓn - 3 mg/ml - ofloxacino 3 mg - ofloxacino